The reduction of CD4 expression on the surface of producer cells by the HIV proteins Nef and Vpu is thought to prevent superinfection by other virions. It could also optimize viral production or infectivity by counteracting negative effects of CD4 on the viral envelope [4] [5] [6] . We have compared the effects of CD4 on two distinct isolates, HIV-1 NL4-3 and HIV-1 SF2 . Proviral DNA was transfected into 293T cells in the absence or presence of a CD4 expression plasmid (Figure 1 , white and black bars) and culture supernatants were harvested 48 hours later. No significant change in the amount of reverse transcriptase activity released into the supernatant was observed in the presence of CD4 (Figure 1a) . This suggested that concentrations of CD4 were not sufficient to block particle release [5] . When, however, the relative infectivity of released particles was tested in an assay of a single round of replication in HeLa-CD4-β-galactosidase (Sx22-1) indicator cells, CD4 expression significantly reduced the relative infectivity of HIV-1 NL4-3 to 30% of that in the absence of CD4 (Figure 1b, left panel) . These results are consistent with published data [6] . In sharp contrast, the relative infectivity of HIV-1 SF2 was increased more than twofold in the presence of CD4 (Figure 1b, right panel) . Notably, the absolute infectivity was up to 10-fold higher for HIV-1 NL4-3 than for HIV-1 SF2 . Thus, depending on the viral isolate, the expression of CD4 on the producer cell can be deleterious or beneficial to HIV-1 infectivity.
Results and discussion
The reduction of CD4 expression on the surface of producer cells by the HIV proteins Nef and Vpu is thought to prevent superinfection by other virions. It could also optimize viral production or infectivity by counteracting negative effects of CD4 on the viral envelope [4] [5] [6] . We have compared the effects of CD4 on two distinct isolates, HIV-1 NL4-3 and HIV-1 SF2 . Proviral DNA was transfected into 293T cells in the absence or presence of a CD4 expression plasmid ( Figure 1 , white and black bars) and culture supernatants were harvested 48 hours later. No significant change in the amount of reverse transcriptase activity released into the supernatant was observed in the presence of CD4 (Figure 1a ). This suggested that concentrations of CD4 were not sufficient to block particle release [5] . When, however, the relative infectivity of released particles was tested in an assay of a single round of replication in HeLa-CD4-β-galactosidase (Sx22-1) indicator cells, CD4 expression significantly reduced the relative infectivity of HIV-1 NL4-3 to 30% of that in the absence of CD4 (Figure 1b, left panel) . These results are consistent with published data [6] . In sharp contrast, the relative infectivity of HIV-1 SF2 was increased more than twofold in the presence of CD4 (Figure 1b, right panel) . Notably, the absolute infectivity was up to 10-fold higher for HIV-1 NL4-3 than for HIV-1 SF2 . Thus, depending on the viral isolate, the expression of CD4 on the producer cell can be deleterious or beneficial to HIV-1 infectivity.
To identify the cause of the different responses of HIV-1 NL4-3 and HIV-1 SF2 to CD4, we tested the subcellular distribution of viral proteins in target cells shortly after infection. When Jurkat cells were fractionated, about 60% of the internalized p24 Gag protein from HIV-1 NL4-3 was detected in the cytosolic fraction ( Figure 2 ). This ratio between vesicular and cytosolic p24 Gag is identical to data for HIV-1 NL4-3 with CEM cells [7] . HIV-1 NL4-3 virions produced in the presence of CD4 displayed a similar subcellular distribution (Figure 2 ). For HIV-1 SF2 , however, only 35-40% of the viral protein was present in the cytosol, suggesting that relatively more HIV-1 SF2 was endocytosed. Interestingly, HIV-1 SF2 virions produced in the presence of CD4 were found almost exclusively (95%) Figure 1 The expression of CD4 in the producer cell has opposite effects on the infectivity of HIV-1 NL4-3 and HIV-1 SF2 . Culture supernatants from 293T cells transfected with proviral DNA in the absence (white bars) or presence (black bars) of a CD4 expression vector were assayed for (a) the amount of RT activity and (b) the relative infectivity of virions produced in a single round of replication. Values in the absence of CD4 were arbitrarily set to 100% for both viruses. Data are average values from at least three independent experiments with standard errors of the mean. in the vesicular fraction of target cells (Figure 2 ). This distribution was similar to that of non-infectious HIV-1 NL4-3 lacking the env gene ( [7] , and data not shown). For HIV-1 SF2 , however, this shift towards the vesicular fraction correlated with increased infectivity (Figure 1b) . We conclude that HIV-1 SF2 can productively enter target cells through endocytic vesicles. As the percentage of the input virus recovered was similar for HIV-1 NL4-3 and HIV-1 SF2 , yet HIV-1 NL4-3 displayed a consistently higher relative infectivity, the entry of HIV-1 SF2 via endocytosis was less efficient than the entry of HIV-1 NL4-3 by fusion.
To confirm that HIV-1 SF2 can infect target cells via endocytosis, we performed assays of a single round of replication in the presence of endocytic inhibitors. By blocking acidification of endocytic vesicles [8] , NH 4 Cl and concanamycin A inhibit viral entry via endocytosis. As previously described [9] , the infectivity of HIV-1 NL4-3 was increased in the presence of NH 4 Cl and concanamycin A by 40-80%, respectively (Figure 3a , HIV-1 NL4-3 ). These endocytic inhibitors increased even more the infectivity of HIV-1 NL4-3 particles produced in the presence of CD4 (Figure 3a , HIV-1 NL4-3 + CD4). In sharp contrast, the infectivity of HIV-1 SF2 was decreased by up to 50% in the presence of both compounds (Figure 3a , HIV-1 SF2 ). Although the concentrations of inhibitors used completely blocked endocytic entry mediated by the G protein of vesicular stomatitis virus (VSV-G) ( [9] , data not shown), the infectivity of HIV-1 SF2 was not completely abolished under these conditions. The infectivity of HIV-1 SF2 virions produced in the presence of CD4 was, however, reduced by 95% (Figure 3a , HIV-1 SF2 + CD4). We conclude that HIV-1 SF2 can infect target cells successfully by an endocytic mechanism and that HIV-1 SF2 virions produced in the presence of CD4 use this route almost exclusively for entry into HeLa cells.
For viruses that enter cells by the endocytic route, fusion is induced by the low pH of the endocytic vesicles [1] . This event can be mimicked by incubating producer cells in acidic medium, which typically results in the formation of syncytia. Consistent with its ability to enter cells by receptor-mediated fusion, no differences were observed in the formation of syncytia at pH 7 and pH 5 in HIV-1 NL4-3 -producing HeLa-CD4-β-galactosidase indicator (P4) cells (Figure 3b , top panel). Large syncytia containing a maximum of 45 nuclei (average 15) were observed at either pH. No syncytia were formed in cells transfected HIV-1 SF2 is present in significantly higher amounts than HIV-1 NL4-3 in the vesicular fraction of target cells. p24 Gag (100 ng) of the respective viruses produced in the absence or presence of CD4 were incubated with Jurkat cells which were then lysed and separated into cytosolic (white bars) and vesicular (black bars) fractions as described in Materials and methods. The amount of p24 Gag in each fraction was determined by ELISA. The relative distribution of p24 Gag between the cytosolic and vesicular fractions is presented. The ratio between cellular and vesicular p24 Gag was constant over one order of magnitude of the amount of input virus. The total amount of captured protein after fractionation ranged between experiments from 0.1-1% of input protein without a change of the relative p24 Gag distribution. Average values from at least three independent experiments are given with standard errors of the mean. with an empty control plasmid vector at either pH (data not shown). In sharp contrast, and although occasional heterokaryons were observed at neutral pH, large syncytia were detected only at pH 5 with HIV-1 SF2 (Figure 3b , bottom panel). With both strains of HIV-1 in permissive conditions the number of syncytia were equivalent. The pH-induced polynuclei formed with HIV-1 SF2 were smaller than those with HIV-1 NL4-3 and contained up to 18 nuclei (average 8). The induction of fusion by low pH was similar but less pronounced than with VSV-G (data not shown). These results show that the fusogenic activity of HIV-1 SF2 can be induced by low pH and confirm that endocytosis is its preferred route of entry into HeLa cells.
Previous results suggested that HIV-1 SF2 can fuse from endocytic vesicles and that the presence of CD4 in the producer cells enhances this activity. Because it has been reported that CD4 drastically reduces the amount of Env in the HIV-1 NL4-3 virion [6] , we analyzed the composition of virions produced in the presence or absence of CD4. 293T cells were co-transfected with our proviruses and a CD4 expression plasmid or an empty control plasmid vector. Cells were metabolically labeled and cell extracts and virus pellets were immunoprecipitated with serum from an AIDS patient. Immunoprecipitations were separated by SDS-PAGE, and proteins visualized by autoradiography. As expected, expression of CD4 in the producer cell resulted in significantly reduced incorporation of both gp120 and gp41 into HIV-1 NL4-3 virions (Figure 4 , compare lanes 6 and 8). In sharp contrast, gp41 was still abundant in HIV-1 SF2 virions produced in the presence of CD4 (Figure 4, lane 4) . As the presence of CD4 reduced cleavage of the gp160 Env precursor to gp120 and gp41 to a similar degree for HIV-1 NL4-3 and HIV-1 SF2 , these different virion compositions were not a consequence of altered Env processing. Thus, whereas HIV-1 NL4-3 virions do not incorporate detectable amounts of viral Env in the presence of CD4, HIV-1 SF2 virions still have gp41. Thus, fusion of these virions out of endocytic vesicles could result from the activation of gp41 by low pH.
Our results demonstrate the existence of HIV-1 isolates that can infect cells via an endocytic mechanism. Although the ability of HIV to enter cells by clathrin-coated vesicles had been documented by electron microscopy [10] [11] [12] and HIV-1 replication can be sensitive to NH 4 Cl [13] , we provide the first evidence that this route of entry can lead to viral integration and early gene expression. It also suggests that the fusogenic activity of gp41 can be activated by low pH similarly to the hemagglutinin protein of influenza virus (see Supplementary material). Although less efficient than receptor-mediated fusion, this endocytic entry could expand the cellular range of HIV, explain its CD4-independent entry [14] and reconcile reports on the replication of HIV-1 SF2 in CD4-negative fibroblasts and glial cells [15] . By this mechanism, HIV might also be able to create many more latent reservoirs, which could represent a major challenge for the eradication of the virus. Moreover, this finding might be relevant for future therapies of AIDS, where blocking CD4 and chemokine receptors could select for 'HIV-1 SF2 ' variants.
Rather, the main goal should be to block the fusion event itself. To this end, several compounds directed against the fusogenic activity of gp41 have been tested with encouraging results in vitro and in vivo [16, 17] .
Materials and methods

Cells, constructs and viruses
293T, Jurkat, Sx22-1 and P4 cells were cultured as described elsewhere [18, 19] . P4 cells were obtained from Ned Landau via the AIDS Research and Reference Reagent Program. Infectious virus was generated by transfecting proviral DNA encoding complete molecular clones into 293T cells using lipofectamine (Gibco) according to the manufacturer's instructions. To produce virus in the presence of CD4, proviral DNA was co-transfected with an expression plasmid for CD4 at 1:1 ratio. Molecular clones for HIV-1 SF2 and HIV-1 NL4-3 were described previously [20, 21] . The expression construct for CD4 was kindly provided by Rafick Sekaly, and the molecular clone lacking the env gene (pNL LucR-E -) was obtained from Ned Landau via the AIDS Research and Reference Reagent Program. Cell culture supernatants were harvested 48 h later, cleared through a 45 mm filter (Millipore) and stored at -80°C or used directly in infectivity assays. The amounts of virus were quantified by determining the reverse transcriptase activity according to standard protocols or by p24 Gag ELISA (NEN Life Science Products).
Infectivity assay
The relative infectivity of virus particles was assayed on the HeLa-CD4-β-Gal indicator cell line Sx22-1 [19] . Sx22-1 cells were infected in 96-well plates with virus stocks for 5 h and then cultured in Brief Communication 1007 
Fusion assay
P4 cells (5 × 10 4 ) were plated on coverslips overnight and transfected with proviral DNA using lipofectamine (Gibco). Twenty-four hours after transfection, the cells were incubated with prewarmed culture medium adjusted to pH 5 or pH 7, for 5 min at 37°C and then grown for another 1 h in regular culture medium. Cells were then fixed, stained with 1% methylene blue in methanol, washed in PBS and analyzed for the presence of syncytia.
Cell fractionation
Separation of cells into cytosolic and vesicular fractions was performed essentially as described in [7] . Briefly, 1 × 10 7 Jurkat cells were incubated for 30 min rocking at 4°C with virus stocks containing 100 ng p24 Gag in a total volume of 1 ml DMEM containing 20 mM HEPES, pH 7.0 and 20 µg/ml DEAE dextran. After extensive washing with PBS, attached virus was allowed to enter cells for 1 h at 37°C followed by digestion of uninternalized particles by pronase (0.1 mg/ml, 2 min, 4°C). Pronase treatment was stopped by the addition of FCS. No background p24 Gag protein was detected on cells that were treated with pronase directly after incubation with virus stock. The cells were then washed in PBS and incubated in swelling buffer (10 mM Tris-HCl, pH 8.0, 10 mM KCL, 1 mM EDTA) for 1 min on ice, followed by homogenization by 5 dounce strokes. The post-nuclear supernatants were ultracentrifuged (12 min, 50,000 rpm, SWTi55 rotor, 4°C) resulting in the cytosolic supernatant and the vesicular pellet. The pellet was resuspended in 20 mM HEPES, 0.5% Triton X-100, 150 mM NaCl, the cytosolic fraction adjusted to 0.5% Triton X-100 and the amounts of viral protein in each fraction were determined by p24 Gag ELISA.
Analysis of virus particles
To determine the composition of virions, 293T cells were transfected with proviral DNA and metabolically labeled with 100 µCi [ 35 S]Met,Cys (Pro-Mix, Amersham Life Science) 36 h post-transfection for 8-12 h. Cell supernatants were collected and virus pellets were generated by ultracentrifugation (2 h, 100,000g, 4°C). Cells and virus pellets were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.2, 1% Triton X-100, 0.1% SDS) for 30 min at 4°C and cleared supernatants (10 min, 14,000g) were immunoprecipitated with serum from an AIDS patient. After 3 h incubation, immunoprecipitates were washed three times in RIPA buffer, separated on 10% SDS-PAGE and visualized by autoradiography.
Supplementary material
Supplementary material including a figure demonstrating opposite effects of soluble CD4 on the infectivity of HIV-1 NL4-3 and HIV-1 SF2 and a model of endocytic entry by HIV-1 is available at http://currentbiology.com/supmat/supmatin.htm.
